Hiroshi Tada

Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study

In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine

Quantitative diagnostic imaging of cancer tissues by using phosphor-integrated dots with ultra-high brightness

L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism

Predictive diagnosis of the risk of breast cancer recurrence after surgery by single-particle quantum dot imaging

Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)

Fatigue and fracture mechanics

Breast Cancer Treatment Studies

HER2/EGFR in Cancer Research

Cancer Genomics and Diagnostics

Advanced Biosensing Techniques and Applications